RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, has launched an informational website to educate patients and the general public about allograft tissue. AllograftInfo.com explores the use of allograft, or human donated tissue, in surgery, as well as provides links to relevant research and articles. The website also addresses several frequently asked questions and provides suggestions on what to ask your surgeon when considering allograft.
“ AllograftInfo.com is a website we created based on surgeon feedback to provide patients a convenient and easy-to-understand portal for self-education on allograft tissue," said Brian K. Hutchison, president and chief executive officer. “RTI believes in the life-changing benefits of allograft implants, and we hope this website helps the public and potential patients better understand allograft tissue as an available option in a variety of surgeries.”
An allograft is tissue surgically transplanted from one person to another. Most allograft tissue is recovered surgically after death; the donor must have consented to the donation before death or the donor’s family must consent after death. Allografts have been used successfully for more than 150 years, and approximately one million allografts are transplanted each year in the United States in procedures that include ACL repair, joint reconstruction in the knee and ankle, meniscal replacement, reconstruction due to cancer or trauma, ridge augmentation in dental procedures, shoulder repair, spinal fusion and urological procedures.
Allografts are used as an alternative to synthetic and metal implants. However, unlike synthetic or metal implants, allografts are natural and biocompatible scaffolds, allowing the recipient’s body to remodel it into his or her own tissue over time. Using allograft tissue rather than an autograft – or tissue from one’s own body – eliminates a second surgical site, allowing the recipient to avoid additional pain, risk and a possible longer hospital stay.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts